About 55% of Canadians are covered by employer-sponsored drug plans, which means that when these workers get laid off, they also lose their health benefits, including prescription drug insurance tied to their jobs.
Novo Nordisk announces Health Canada has granted priority review status for once-weekly semaglutide to treat metabolic dysfunction-associated steatohepatitis.
A panel of dermatologists develops core principles, consensus statements and a treatment algorithm for the management of atopic dermatitis with topical products.
Though more research is needed on why there were fewer asthma visits during the later wave of wildfire smoke, the authors believe public awareness during the first wave, including air quality advisories, led people to take measures to protect themselves.
